Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:hormone |
| gptkbp:administeredBy |
injection
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:G03GA04
|
| gptkbp:brand |
Bravelle
Metrodin |
| gptkbp:contains |
gptkb:follicle-stimulating_hormone
|
| gptkbp:derivedFrom |
urine of postmenopausal women
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:pregnancyCategory |
X
|
| gptkbp:routeOfAdministration |
intramuscular
subcutaneous |
| gptkbp:sideEffect |
abdominal pain
headache injection site reaction ovarian hyperstimulation syndrome |
| gptkbp:usedFor |
infertility treatment
|
| gptkbp:usedIn |
gptkb:assisted_reproductive_technology
|
| gptkbp:bfsParent |
gptkb:Fostimon
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
urofollitropin
|